LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 29.00% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 249.60M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 32.65%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 32.65%.
Undervalued
The company’s latest PE is 34.89, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 23.53M shares, increasing 3.50% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 10.24K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.90.